Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE: Feasibility of IPTp-DP in Kenya
NCT04160026Phase 4Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Nov 2019
- Primary completion
- Jul 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin, piperaquine in malaria, sponsored by Liverpool School of Tropical Medicine. Started Nov 2019; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04160026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04160026.